醫學教育

Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy

作者:Zhipeng Sun1 and Nengwei Zhang2 來源:醫學論壇網 日期:2017-11-15
導讀

Abstract Background: In the clinical practice of neoadjuvant chemotherapy, response markers are very important. We aimed o investigate whether tumor markers CEA(carcino-embryonic antigen), CA19-9(carbohydrate antigen 19–9), CA72-4(carbohydrate antigen 72

關鍵字: Gastric | cancer | | Neoadjuvant | chemotherapy | | CEA | | CA19-9 | | CA72-4 | | CA125
Abstract
Background:In the clinical practice of Neoadjuvant chemotherapy, response markers are very important. We aimed
o investigate whether tumor markers CEA(carcino-embryonic antigen), CA19-9(carbohydrate antigen 19–9), CA72-4
(carbohydrate antigen 72–4), and CA125(carbohydrate antigen 125) can be used to evaluate the response to
neoadjuvant chemotherapy, and to evaluate the diagnosis and prognosis value of four tumor markers in the patients of Gastric cancer.
閱讀全文請見: Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
分享:

相關文章

    評論

    我要跟帖
    發表
    回複 小鴨梨
    發表

    copyright©醫學論壇網 版權所有,未經許可不得複製、轉載或鏡像

    京ICP證120392號 京公網安備110105007198 京ICP備10215607號-1 (京)網藥械信息備字(2022)第00160號
    //站內統計//百度統計//穀歌統計//站長統計
    *我要反饋: 姓 名: 郵 箱: